 | Up a level |
HajhosseinTalasaz, A. and Kakavand, H. and Van Tassell, B. and Aghakouchakzadeh, M. and Sadeghipour, P. and Dunn, S. and Geraiely, B. (2021) Cardiovascular Complications of COVID-19: Pharmacotherapy Perspective. Cardiovascular Drugs and Therapy, 35 (2). pp. 249-259.
Talasaz, A.H. and Sadeghipour, P. and Kakavand, H. and Aghakouchakzadeh, M. and Kordzadeh-Kermani, E. and Van Tassell, B.W. and Gheymati, A. and Ariannejad, H. and Hosseini, S.H. and Jamalkhani, S. and Sholzberg, M. and Monreal, M. and Jimenez, D. and Piazza, G. and Parikh, S.A. and Kirtane, A.J. and Eikelboom, J.W. and Connors, J.M. and Hunt, B.J. and Konstantinides, S.V. and Cushman, M. and Weitz, J.I. and Stone, G.W. and Krumholz, H.M. and Lip, G.Y.H. and Goldhaber, S.Z. and Bikdeli, B. (2021) Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19: JACC State-of-the-Art Review. Journal of the American College of Cardiology, 77 (15). pp. 1903-1921.
